NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE Drug Patent Profile
✉ Email this page to a colleague
When do Neomycin Sulfate-triamcinolone Acetonide patents expire, and what generic alternatives are available?
Neomycin Sulfate-triamcinolone Acetonide is a drug marketed by Fougera and Pharmaderm and is included in four NDAs.
The generic ingredient in NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE?
- What are the global sales for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE?
- What is Average Wholesale Price for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE?
Summary for NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
DailyMed Link: | NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE at DailyMed |